Therapeutic Anticoagulation with Argatroban and Heparins Reduces Granulocyte Migration: Possible Impact on ECLS-Therapy?

INTRODUCTION: Anticoagulants such as argatroban and heparins (low-molecular-weight and unfractionated) play an immense role in preventing thromboembolic complications in clinical practice. Nevertheless, they can also have a negative effect on the immune system. This study is aimed at investigating t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bredthauer, Andre, Kopfmueller, Manuel, Gruber, Michael, Pfaehler, Sophie-Marie, Lehle, Karla, Petermichl, Walter, Seyfried, Timo, Bitzinger, Diane, Redel, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196999/
https://www.ncbi.nlm.nih.gov/pubmed/32405324
http://dx.doi.org/10.1155/2020/9783630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196999/
https://www.ncbi.nlm.nih.gov/pubmed/32405324
http://dx.doi.org/10.1155/2020/9783630

Ejemplares similares